Next-Gen Infusion Pump

Jan 15, 2026 → Nov 30, 2026 3 team members

Phase 1

Design & Engineering

Phase 2

Manufacture & Assembly

Phase 3

Quality & Support

Progress

62%

SPI

0.91

≥ 0.95 healthy

CPI

0.94

≥ 0.95 healthy

Quality

≥ 85 healthy

Benchmark grading

Product PM (PMI/ISO 21500)

At risk

Commercial product portfolios tolerate moderate schedule and cost variance as long as scope and quality are protected. Bands reflect typical earned-value reporting in hardware and firmware programs.

Schedule (SPI)0.91 / ≥ 0.95

Cost (CPI)0.94 / ≥ 0.95

Quality88 / ≥ 85

Open critical defects1 / ≤ 0

Source: PMI PMBOK 7 · ISO 21500

Top AI insights

AI generated

Schedule · AI

IEC 60601 testing likely to slip 2–3 weeks

Pilot run completion is trending 9 days late and feeds directly into safety testing. Probability of milestone slip: 78%.

Cost · AI

Predicted EAC $110K over budget

BOM components and tooling both ran 5–10% over plan. Projecting final cost at $1.96M vs $1.85M budget.

Quality · AI

Firmware defects cluster around alarm subsystem

3 of last 5 defects (incl. 1 critical) trace to alarm/event handling. Recommend dedicated code review before next pilot run.

Team

Lena Park

Customer Lead

Wei Chen

Priya Nair

QA Lead